Across TCGA pan-cancer cohorts, CLCA1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CLCA1’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where CLCA1 RNA is repressed in tumor relative to normal tissue. In most cancer types CLCA1 is over-expressed in tumor, although a few such as COAD and READ show the opposite, repressed pattern.
COAD, READ, and KICH are the cancer types where CLCA1 tumor–normal differential expression is most reproducible.